{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:19:51Z","timestamp":1793762391347,"version":"4.6.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK121948"],"award-info":[{"award-number":["DK121948"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK086738"],"award-info":[{"award-number":["DK086738"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["196F14a"],"award-info":[{"award-number":["196F14a"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["196F14a"],"award-info":[{"award-number":["196F14a"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amy P. Goldman Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41588-021-00946-4","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T12:12:33Z","timestamp":1633954353000},"page":"1649-1663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Renal plasticity revealed through reversal of polycystic kidney disease in mice"],"prefix":"10.1038","volume":"53","author":[{"given":"Ke","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Coman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmeed","family":"Hyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5062-4629","authenticated-orcid":false,"given":"Stefan","family":"Somlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"946_CR1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","volume":"124","author":"PC Harris","year":"2014","unstructured":"Harris, P. C. & Torres, V. E. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J. Clin. Invest. 124, 2315\u20132324 (2014).","journal-title":"J. Clin. Invest."},{"key":"946_CR2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0092-8674(00)81793-6","volume":"87","author":"F Qian","year":"1996","unstructured":"Qian, F., Watnick, T. J., Onuchic, L. F. & Germino, G. G. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 87, 979\u2013987 (1996).","journal-title":"Cell"},{"key":"946_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","volume":"93","author":"G Wu","year":"1998","unstructured":"Wu, G. et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93, 177\u2013188 (1998).","journal-title":"Cell"},{"key":"946_CR4","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1681\/ASN.2016040425","volume":"27","author":"WN Leonhard","year":"2016","unstructured":"Leonhard, W. N., Happe, H. & Peters, D. J. Variable cyst development in autosomal dominant polycystic kidney disease: the biologic context. J. Am. Soc. Nephrol. 27, 3530\u20133538 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR5","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","volume":"13","author":"K Piontek","year":"2007","unstructured":"Piontek, K., Menezes, L. F., Garcia-Gonzalez, M. A., Huso, D. L. & Germino, G. G. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 13, 1490\u20131495 (2007).","journal-title":"Nat. Med."},{"key":"946_CR6","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1093\/hmg\/ddm299","volume":"16","author":"IS Lantinga-van Leeuwen","year":"2007","unstructured":"Lantinga-van Leeuwen, I. S. et al. Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum. Mol. Genet. 16, 3188\u20133196 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"946_CR7","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cub.2007.08.034","volume":"17","author":"JR Davenport","year":"2007","unstructured":"Davenport, J. R. et al. Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr. Biol. 17, 1586\u20131594 (2007).","journal-title":"Curr. Biol."},{"key":"946_CR8","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/hmg\/ddp147","volume":"18","author":"A Takakura","year":"2009","unstructured":"Takakura, A. et al. Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum. Mol. Genet. 18, 2523\u20132531 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"946_CR9","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","volume":"17","author":"V Patel","year":"2008","unstructured":"Patel, V. et al. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 17, 1578\u20131590 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"946_CR10","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1681\/ASN.2008040435","volume":"20","author":"AP Bastos","year":"2009","unstructured":"Bastos, A. P. et al. Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia\/reperfusion. J. Am. Soc. Nephrol. 20, 2389\u20132402 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR11","doi-asserted-by":"crossref","first-page":"109648","DOI":"10.1016\/j.cellsig.2020.109648","volume":"72","author":"C Formica","year":"2020","unstructured":"Formica, C. & Peters, D. J. M. Molecular pathways involved in injury-repair and ADPKD progression. Cell Signal. 72, 109648 (2020).","journal-title":"Cell Signal."},{"key":"946_CR12","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","volume":"22","author":"A Karihaloo","year":"2011","unstructured":"Karihaloo, A. et al. Macrophages promote cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 22, 1809\u20131814 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR13","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1172\/JCI80467","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen, L. et al. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. J. Clin. Invest. 125, 2399\u20132412 (2015).","journal-title":"J. Clin. Invest."},{"key":"946_CR14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","volume":"83","author":"KI Swenson-Fields","year":"2013","unstructured":"Swenson-Fields, K. I. et al. Macrophages promote polycystic kidney disease progression. Kidney Int. 83, 855\u2013864 (2013).","journal-title":"Kidney Int."},{"key":"946_CR15","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2018050518","volume":"29","author":"MF Cassini","year":"2018","unstructured":"Cassini, M. F. et al. Mcp1 promotes macrophage-dependent cyst expansion in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 29, 2471\u20132481 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-51436-9_12","volume":"60","author":"CJ Song","year":"2017","unstructured":"Song, C. J., Zimmerman, K. A., Henke, S. J. & Yoder, B. K. Inflammation and fibrosis in polycystic kidney disease. Results Probl. Cell Differ. 60, 323\u2013344 (2017).","journal-title":"Results Probl. Cell Differ."},{"key":"946_CR17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall, E. et al. Type of PKD1 mutation influences renal outcome in ADPKD. J. Am. Soc. Nephrol. 24, 1006\u20131013 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ng.860","volume":"43","author":"SV Fedeles","year":"2011","unstructured":"Fedeles, S. V. et al. A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat. Genet. 43, 639\u2013647 (2011).","journal-title":"Nat. Genet."},{"key":"946_CR19","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","volume":"122","author":"K Hopp","year":"2012","unstructured":"Hopp, K. et al. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J. Clin. Invest. 122, 4257\u20134273 (2012).","journal-title":"J. Clin. Invest."},{"key":"946_CR20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830\u2013840 (2010).","journal-title":"N. Engl. J. Med."},{"key":"946_CR21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra, A. L. et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820\u2013829 (2010).","journal-title":"N. Engl. J. Med."},{"key":"946_CR22","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres, V. E. et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 367, 2407\u20132418 (2012).","journal-title":"N. Engl. J. Med."},{"key":"946_CR23","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres, V. E. et al. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N. Engl. J. Med. 377, 1930\u20131942 (2017).","journal-title":"N. Engl. J. Med."},{"key":"946_CR24","doi-asserted-by":"crossref","unstructured":"Calvet, J. P. The role of calcium and cyclic AMP in PKD. in Polycystic Kidney Disease (ed. Li, X.) 169-196 (Codon Publications, 2015).","DOI":"10.15586\/codon.pkd.2015.ch8"},{"key":"946_CR25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jmcb\/mjw022","volume":"8","author":"VR Kakade","year":"2016","unstructured":"Kakade, V. R. et al. A cAMP and CREB-mediated feed-forward mechanism regulates GSK3beta in polycystic kidney disease. J. Mol. Cell. Biol. 8, 464\u2013476 (2016).","journal-title":"J. Mol. Cell. Biol."},{"key":"946_CR26","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1093\/hmg\/ddy223","volume":"27","author":"SC Parnell","year":"2018","unstructured":"Parnell, S. C. et al. A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD. Hum. Mol. Genet. 27, 3313\u20133324 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"946_CR27","doi-asserted-by":"crossref","first-page":"dev158931","DOI":"10.1242\/dev.158931","volume":"145","author":"B Zhang","year":"2018","unstructured":"Zhang, B., Tran, U. & Wessely, O. Polycystin 1 loss of function is directly linked to an imbalance in G-protein signaling in the kidney. Development 145, dev158931 (2018).","journal-title":"Development"},{"key":"946_CR28","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.90277.2008","volume":"297","author":"L Tsiokas","year":"2009","unstructured":"Tsiokas, L. Function and regulation of TRPP2 at the plasma membrane. Am. J. Physiol. Renal Physiol. 297, F1\u2013F9 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"946_CR29","doi-asserted-by":"crossref","first-page":"F395","DOI":"10.1152\/ajprenal.00057.2018","volume":"315","author":"KR Kipp","year":"2018","unstructured":"Kipp, K. R. et al. Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease. Am. J. Physiol. Renal Physiol. 315, F395\u2013F405 (2018).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"946_CR30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2016.108","volume":"12","author":"D Fantus","year":"2016","unstructured":"Fantus, D., Rogers, N. M., Grahammer, F., Huber, T. B. & Thomson, A. W. Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. Nat. Rev. Nephrol. 12, 587\u2013609 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"946_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","volume":"21","author":"JM Shillingford","year":"2010","unstructured":"Shillingford, J. M., Piontek, K. B., Germino, G. G. & Weimbs, T. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J. Am. Soc. Nephrol. 21, 489\u2013497 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12832","volume":"504","author":"PG DeCaen","year":"2013","unstructured":"DeCaen, P. G., Delling, M., Vien, T. N. & Clapham, D. E. Direct recording and molecular identification of the calcium channel of primary cilia. Nature 504, 315\u2013318 (2013).","journal-title":"Nature"},{"key":"946_CR33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature12833","volume":"504","author":"M Delling","year":"2013","unstructured":"Delling, M., DeCaen, P. G., Doerner, J. F., Febvay, S. & Clapham, D. E. Primary cilia are specialized calcium signalling organelles. Nature 504, 311\u2013314 (2013).","journal-title":"Nature"},{"key":"946_CR34","doi-asserted-by":"crossref","first-page":"e60684","DOI":"10.7554\/eLife.60684","volume":"9","author":"K Ha","year":"2020","unstructured":"Ha, K. et al. The heteromeric PC-1\/PC-2 polycystin complex is activated by the PC-1 N-terminus. eLife 9, e60684 (2020).","journal-title":"eLife"},{"key":"946_CR35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrneph.2016.91","volume":"12","author":"LR Harskamp","year":"2016","unstructured":"Harskamp, L. R., Gansevoort, R. T., van Goor, H. & Meijer, E. The epidermal growth factor receptor pathway in chronic kidney diseases. Nat. Rev. Nephrol. 12, 496\u2013506 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"946_CR36","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4161\/cc.22375","volume":"11","author":"NO Bukanov","year":"2012","unstructured":"Bukanov, N. O. et al. CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD. Cell Cycle 11, 4040\u20134046 (2012).","journal-title":"Cell Cycle"},{"key":"946_CR37","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1681\/ASN.2013111179","volume":"26","author":"K Lee","year":"2015","unstructured":"Lee, K., Boctor, S., Barisoni, L. M. & Gusella, G. L. Inactivation of integrin-beta1 prevents the development of polycystic kidney disease after the loss of polycystin-1. J. Am. Soc. Nephrol. 26, 888\u2013895 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR38","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1681\/ASN.2016111235","volume":"28","author":"A Raman","year":"2017","unstructured":"Raman, A. et al. Integrin-linked kinase signaling promotes cyst growth and fibrosis in polycystic kidney disease. J. Am. Soc. Nephrol. 28, 2708\u20132719 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR39","doi-asserted-by":"crossref","unstructured":"Li, X. Epigenetics in ADPKD: understanding mechanisms and discovering treatment. in Polycystic Kidney Disease (ed. Li, X.) 283-312 (Codon Publications, 2015).","DOI":"10.15586\/codon.pkd.2015.ch12"},{"key":"946_CR40","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/ndt\/gfx262","volume":"33","author":"MY Chang","year":"2017","unstructured":"Chang, M. Y. & Ong, A. C. M. Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 33, 1310\u20131316 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"key":"946_CR41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","volume":"19","author":"I Rowe","year":"2013","unstructured":"Rowe, I. et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 19, 488\u2013493 (2013).","journal-title":"Nat. Med."},{"key":"946_CR42","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.2015030231","volume":"27","author":"M Chiaravalli","year":"2016","unstructured":"Chiaravalli, M. et al. 2-Deoxy-d-glucose ameliorates PKD progression. J. Am. Soc. Nephrol. 27, 1958\u20131969 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR43","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41581-018-0051-1","volume":"14","author":"V Padovano","year":"2018","unstructured":"Padovano, V., Podrini, C., Boletta, A. & Caplan, M. J. Metabolism and mitochondria in polycystic kidney disease research and therapy. Nat. Rev. Nephrol. 14, 678\u2013687 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"946_CR44","volume":"9","author":"EM Flowers","year":"2018","unstructured":"Flowers, E. M. et al. Lkb1 deficiency confers glutamine dependency in polycystic kidney disease. Nat. Commun. 9, 814 (2018).","journal-title":"Nat. Commun."},{"key":"946_CR45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ncb3363","volume":"18","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. The polycystin complex mediates Wnt\/Ca2+ signalling. Nat. Cell Biol. 18, 752\u2013764 (2016).","journal-title":"Nat. Cell Biol."},{"key":"946_CR46","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"M Ma","year":"2013","unstructured":"Ma, M., Tian, X., Igarashi, P., Pazour, G. J. & Somlo, S. Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat. Genet. 45, 1004\u20131012 (2013).","journal-title":"Nat. Genet."},{"key":"946_CR47","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bbadis.2010.11.014","volume":"1812","author":"V Takiar","year":"2011","unstructured":"Takiar, V. & Caplan, M. J. Polycystic kidney disease: pathogenesis and potential therapies. Biochim. Biophys. Acta 1812, 1337\u20131343 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"946_CR48","doi-asserted-by":"crossref","unstructured":"Avasthi, P., Maser, R.L. & Tran, P.V. in Kidney Development and Disease (ed. Miller, R.K.) 281\u2013321 (Springer International Publishing, 2017).","DOI":"10.1007\/978-3-319-51436-9_11"},{"key":"946_CR49","doi-asserted-by":"crossref","first-page":"a028209","DOI":"10.1101\/cshperspect.a028209","volume":"9","author":"M Ma","year":"2017","unstructured":"Ma, M., Gallagher, A. R. & Somlo, S. Ciliary mechanisms of cyst formation in polycystic kidney disease. Cold Spring Harb. Perspect. Biol. 9, a028209 (2017).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"946_CR50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.celrep.2012.07.004","volume":"2","author":"Z Lao","year":"2012","unstructured":"Lao, Z., Raju, G. P., Bai, C. B. & Joyner, A. L. MASTR: a technique for mosaic mutant analysis with spatial and temporal control of recombination using conditional floxed alleles in mice. Cell Rep. 2, 386\u2013396 (2012).","journal-title":"Cell Rep."},{"key":"946_CR51","first-page":"1155","volume":"8","author":"M Zhang","year":"2015","unstructured":"Zhang, M. & Kirsch, D. G. The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis. Dis. Model Mech. 8, 1155\u20131166 (2015).","journal-title":"Dis. Model Mech."},{"key":"946_CR52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1172\/JCI22850","volume":"115","author":"S Nishio","year":"2005","unstructured":"Nishio, S. et al. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J. Clin. Invest. 115, 910\u2013918 (2005).","journal-title":"J. Clin. Invest."},{"key":"946_CR53","doi-asserted-by":"crossref","first-page":"F870","DOI":"10.1152\/ajprenal.00153.2003","volume":"285","author":"RB Thomson","year":"2003","unstructured":"Thomson, R. B. et al. Histopathological analysis of renal cystic epithelia in the Pkd2WS25\/- mouse model of ADPKD. Am. J. Physiol. Renal Physiol. 285, F870\u2013F880 (2003).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"946_CR54","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2353\/ajpath.2010.090658","volume":"176","author":"A Stroope","year":"2010","unstructured":"Stroope, A. et al. Hepato-renal pathology in Pkd2ws25\/- mice, an animal model of autosomal dominant polycystic kidney disease. Am. J. Pathol. 176, 1282\u20131291 (2010).","journal-title":"Am. J. Pathol."},{"key":"946_CR55","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima, N. & Komatsu, M. Autophagy: renovation of cells and tissues. Cell 147, 728\u2013741 (2011).","journal-title":"Cell"},{"key":"946_CR56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","volume":"16","author":"C Tang","year":"2020","unstructured":"Tang, C., Livingston, M. J., Liu, Z. & Dong, Z. Autophagy in kidney homeostasis and disease. Nat. Rev. Nephrol. 16, 489\u2013508 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"946_CR57","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","volume":"17","author":"S Shibazaki","year":"2008","unstructured":"Shibazaki, S. et al. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum. Mol. Genet. 17, 1505\u20131516 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"946_CR58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","volume":"30","author":"JA Torres","year":"2019","unstructured":"Torres, J. A. et al. Ketosis ameliorates renal cyst growth in polycystic kidney disease. Cell Metab. 30, 1007\u20131023 (2019).","journal-title":"Cell Metab."},{"key":"946_CR59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.kint.2016.10.039","volume":"91","author":"M Fragiadaki","year":"2017","unstructured":"Fragiadaki, M. et al. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease. Kidney Int. 91, 575\u2013586 (2017).","journal-title":"Kidney Int."},{"key":"946_CR60","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.celrep.2017.05.022","volume":"19","author":"T Zerjatke","year":"2017","unstructured":"Zerjatke, T. et al. Quantitative cell cycle analysis based on an endogenous all-in-one reporter for cell tracking and classification. Cell Rep. 19, 1953\u20131966 (2017).","journal-title":"Cell Rep."},{"key":"946_CR61","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1172\/JCI90921","volume":"127","author":"LX Li","year":"2017","unstructured":"Li, L. X. et al. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease. J. Clin. Invest. 127, 2751\u20132764 (2017).","journal-title":"J. Clin. Invest."},{"key":"946_CR62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1681\/ASN.2020040511","volume":"32","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Cyclin-dependent kinase 1 activity is a driver of cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 32, 41\u201351 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR63","doi-asserted-by":"crossref","first-page":"109647","DOI":"10.1016\/j.cellsig.2020.109647","volume":"73","author":"KA Zimmerman","year":"2020","unstructured":"Zimmerman, K. A., Hopp, K. & Mrug, M. Role of chemokines, innate and adaptive immunity. Cell Signal. 73, 109647 (2020).","journal-title":"Cell Signal."},{"key":"946_CR64","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","volume":"14","author":"D Zheng","year":"2003","unstructured":"Zheng, D. et al. Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 14, 2588\u20132595 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR65","first-page":"969","volume":"32","author":"JJ Grantham","year":"2017","unstructured":"Grantham, J. J. et al. Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease. Nephrol. Dial. Transplant. 32, 969\u2013975 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"key":"946_CR66","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.kint.2020.02.012","volume":"98","author":"M Lannoy","year":"2020","unstructured":"Lannoy, M. et al. The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo. Kidney Int. 98, 404\u2013419 (2020).","journal-title":"Kidney Int."},{"key":"946_CR67","doi-asserted-by":"crossref","first-page":"e133785","DOI":"10.1172\/jci.insight.133785","volume":"5","author":"R Lakhia","year":"2020","unstructured":"Lakhia, R. et al. Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression. JCI Insight 5, e133785 (2020).","journal-title":"JCI Insight"},{"key":"946_CR68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00418-005-0788-z","volume":"123","author":"M Le Hir","year":"2005","unstructured":"Le Hir, M., Hegyi, I., Cueni-Loffing, D., Loffing, J. & Kaissling, B. Characterization of renal interstitial fibroblast-specific protein 1\/S100A4-positive cells in healthy and inflamed rodent kidneys. Histochem. Cell Biol. 123, 335\u2013346 (2005).","journal-title":"Histochem. Cell Biol."},{"key":"946_CR69","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1073\/pnas.1017547108","volume":"108","author":"CH \u00d6sterreicher","year":"2011","unstructured":"\u00d6sterreicher, C. H. et al. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc. Natl Acad. Sci. USA 108, 308\u2013313 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"946_CR70","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/ndt\/gfk047","volume":"21","author":"SK Jo","year":"2006","unstructured":"Jo, S. K., Sung, S. A., Cho, W. Y., Go, K. J. & Kim, H. K. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol. Dial. Transplant. 21, 1231\u20131239 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"946_CR71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.kint.2018.02.026","volume":"94","author":"K Durlacher-Betzer","year":"2018","unstructured":"Durlacher-Betzer, K. et al. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int. 94, 315\u2013325 (2018).","journal-title":"Kidney Int."},{"key":"946_CR72","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1681\/ASN.2003090757","volume":"16","author":"ML Kielar","year":"2005","unstructured":"Kielar, M. L. et al. Maladaptive role of IL-6 in ischemic acute renal failure. J. Am. Soc. Nephrol. 16, 3315\u20133325 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ndt\/gfu296","volume":"30","author":"K Ravichandran","year":"2015","unstructured":"Ravichandran, K., Zafar, I., Ozkok, A. & Edelstein, C. L. An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease. Nephrol. Dial. Transplant. 30, 45\u201353 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"946_CR74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2215\/CJN.04140510","volume":"6","author":"V Menon","year":"2011","unstructured":"Menon, V. et al. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 7\u201313 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"946_CR75","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm1783","volume":"14","author":"X Li","year":"2008","unstructured":"Li, X. et al. A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat. Med. 14, 863\u2013868 (2008).","journal-title":"Nat. Med."},{"key":"946_CR76","doi-asserted-by":"crossref","first-page":"e0131043","DOI":"10.1371\/journal.pone.0131043","volume":"10","author":"JX Zhou","year":"2015","unstructured":"Zhou, J. X., Fan, L. X., Li, X., Calvet, J. P. & Li, X. TNFalpha signaling regulates cystic epithelial cell proliferation through Akt\/mTOR and ERK\/MAPK\/Cdk2 mediated Id2 signaling. PLoS ONE 10, e0131043 (2015).","journal-title":"PLoS ONE"},{"key":"946_CR77","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1172\/JCI90699","volume":"127","author":"MD McGeough","year":"2017","unstructured":"McGeough, M. D. et al. TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies. J. Clin. Invest. 127, 4488\u20134497 (2017).","journal-title":"J. Clin. Invest."},{"key":"946_CR78","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1111\/j.1742-4658.2007.05969.x","volume":"274","author":"N Jain","year":"2007","unstructured":"Jain, N., Sudhakar, C. & Swarup, G. Tumor necrosis factor-alpha-induced caspase-1 gene expression. Role of p73. FEBS J. 274, 4396\u20134407 (2007).","journal-title":"FEBS J."},{"key":"946_CR79","doi-asserted-by":"crossref","first-page":"e71477","DOI":"10.1371\/journal.pone.0071477","volume":"8","author":"S Alvarez","year":"2013","unstructured":"Alvarez, S. & Munoz-Fernandez, M. A. TNF-alpha may mediate inflammasome activation in the absence of bacterial infection in more than one way. PLoS ONE 8, e71477 (2013).","journal-title":"PLoS ONE"},{"key":"946_CR80","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI63679","volume":"123","author":"SR Mulay","year":"2013","unstructured":"Mulay, S. R. et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion. J. Clin. Invest. 123, 236\u2013246 (2013).","journal-title":"J. Clin. Invest."},{"key":"946_CR81","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2013.207","volume":"84","author":"F Knauf","year":"2013","unstructured":"Knauf, F. et al. NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy. Kidney Int. 84, 895\u2013901 (2013).","journal-title":"Kidney Int."},{"key":"946_CR82","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1172\/JCI128503","volume":"130","author":"JA Torres","year":"2019","unstructured":"Torres, J. A. et al. Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease. J. Clin. Invest. 130, 4506\u20134522 (2019).","journal-title":"J. Clin. Invest."},{"key":"946_CR83","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1242\/dmm.003194","volume":"3","author":"S Mangos","year":"2010","unstructured":"Mangos, S. et al. The ADPKD genes Pkd1a\/b and Pkd2 regulate extracellular matrix formation. Dis. Model Mech. 3, 354\u2013365 (2010).","journal-title":"Dis. Model Mech."},{"key":"946_CR84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2734","volume":"222","author":"S Hassane","year":"2010","unstructured":"Hassane, S. et al. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease. J. Pathol. 222, 21\u201331 (2010).","journal-title":"J. Pathol."},{"key":"946_CR85","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1681\/ASN.2020020190","volume":"31","author":"N Dwivedi","year":"2020","unstructured":"Dwivedi, N. et al. Epithelial vasopressin type-2 receptors regulate myofibroblasts by a YAP-CCN2-dependent mechanism in polycystic kidney disease. J. Am. Soc. Nephrol. 31, 1697\u20131710 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"946_CR86","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans, C., Chou, J. & Werb, Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15, 786\u2013801 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"946_CR87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","volume":"5","author":"LF Menezes","year":"2016","unstructured":"Menezes, L. F., Lin, C. C., Zhou, F. & Germino, G. G. Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease. eBioMedicine 5, 183\u2013192 (2016).","journal-title":"eBioMedicine"},{"key":"946_CR88","first-page":"158","volume":"26","author":"P Zhu","year":"2017","unstructured":"Zhu, P., Sieben, C. J., Xu, X., Harris, P. C. & Lin, X. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model. Hum. Mol. Genet. 26, 158\u2013172 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"946_CR89","doi-asserted-by":"publisher","unstructured":"Peintner, L. et al. Loss of PKD1\/polycystin-1 impairs lysosomal activity in a CAPN (calpain)-dependent manner. Autophagy https:\/\/doi.org\/10.1080\/15548627.2020.1826716 (2020).","DOI":"10.1080\/15548627.2020.1826716"},{"key":"946_CR90","doi-asserted-by":"crossref","first-page":"F1235","DOI":"10.1152\/ajprenal.00348.2010","volume":"300","author":"F Belibi","year":"2011","unstructured":"Belibi, F. et al. Hypoxia-inducible factor-1alpha (HIF-1alpha) and autophagy in polycystic kidney disease (PKD). Am. J. Physiol. Renal Physiol. 300, F1235\u2013F1243 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"946_CR91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/nu11010042","volume":"11","author":"LF Chou","year":"2018","unstructured":"Chou, L. F. et al. Effect of trehalose supplementation on autophagy and cystogenesis in a mouse model of polycystic kidney disease. Nutrients 11, 42 (2018).","journal-title":"Nutrients"},{"key":"946_CR92","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yjmcc.2018.03.002","volume":"118","author":"A Criollo","year":"2018","unstructured":"Criollo, A. et al. Polycystin-2-dependent control of cardiomyocyte autophagy. J. Mol. Cell. Cardiol. 118, 110\u2013121 (2018).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"946_CR93","doi-asserted-by":"crossref","first-page":"C198","DOI":"10.1152\/ajpcell.00336.2014","volume":"308","author":"HA Praetorius","year":"2015","unstructured":"Praetorius, H. A. The primary cilium as sensor of fluid flow: new building blocks to the model. A review in the theme: cell signaling: proteins, pathways and mechanisms. Am. J. Physiol. Cell Physiol. 308, C198\u2013C208 (2015).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"946_CR94","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham, J. J. et al. Volume progression in polycystic kidney disease. N. Engl. J. Med. 354, 2122\u20132130 (2006).","journal-title":"N. Engl. J. Med."},{"key":"946_CR95","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12033-009-9142-3","volume":"42","author":"S Wang","year":"2009","unstructured":"Wang, S., Zhao, Y., Leiby, M. & Zhu, J. A new positive\/negative selection scheme for precise BAC recombineering. Mol. Biotechnol. 42, 110\u2013116 (2009).","journal-title":"Mol. Biotechnol."},{"key":"946_CR96","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/gni035","volume":"33","author":"S Warming","year":"2005","unstructured":"Warming, S., Costantino, N., Court, D. L., Jenkins, N. A. & Copeland, N. G. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33, e36 (2005).","journal-title":"Nucleic Acids Res."},{"key":"946_CR97","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1172\/JCI67273","volume":"124","author":"Y Cai","year":"2014","unstructured":"Cai, Y. et al. Altered trafficking and stability of polycystins underlie polycystic kidney disease. J. Clin. Invest. 124, 5129\u20135144 (2014).","journal-title":"J. Clin. Invest."},{"key":"946_CR98","doi-asserted-by":"crossref","first-page":"34302","DOI":"10.1074\/jbc.M405608200","volume":"279","author":"Z Zou","year":"2004","unstructured":"Zou, Z. et al. Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule. J. Biol. Chem. 279, 34302\u201334310 (2004).","journal-title":"J. Biol. Chem."},{"key":"946_CR99","doi-asserted-by":"crossref","first-page":"28557","DOI":"10.1074\/jbc.274.40.28557","volume":"274","author":"Y Cai","year":"1999","unstructured":"Cai, Y. et al. Identification and characterization of polycystin-2, the PKD2 gene product. J. Biol. Chem. 274, 28557\u201328565 (1999).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-021-00946-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-021-00946-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-021-00946-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T11:19:38Z","timestamp":1638789578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-021-00946-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":99,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1038\/s41588-021-00946-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740961751.793593516","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.740961751.793590308","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"24 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}